Data as of Q4 2025 (Dec 31, 2025)

CM Management, LLC

•CIK: 1841857•Filing: Q4 2025

CM Management, LLC manages $119M across a diversified portfolio of 62 positions. The fund exhibits concentrated exposure, with top holdings including RI2 and TGB, each representing $9.6M. Further significant allocations are noted in ALCO at $7.3M and AM6 at $5.3M. This structure suggests a tactical, high-conviction approach across its investment universe.

Total AUM
$118.6M
QoQ Performance
-1.1%
Positions
62
Top 10 Concentration
45.6%
Latest Filing
Q4 2025

Top Holdings Allocation

RI2
TGB
ALCO
RI28.1%
TGB8.1%
ALCO6.1%
AM64.4%
PLPC4.4%
RLGT3.5%
BGC3.0%
NMRK2.8%

📈 Biggest Buys

ARE
ALEXANDRIA REAL ESTATE EQ IN
NEW
1.2% of portfolio
SRCE
1ST SOURCE CORP
NEW
0.9% of portfolio
RPRX
ROYALTY PHARMA PLC SHS
+50.0%
2.4% of portfolio
CMCO
COLUMBUS MCKINNON CORP N Y
NEW
0.8% of portfolio
LYB
LYONDELLBASELL INDUSTRIES N
+200.0%
1.1% of portfolio

📉 Biggest Sells

ARKO
ARKO CORP
-42.9%
1.5% of portfolio
AM6
AMICUS THERAPEUTICS INC
-17.8%
4.4% of portfolio
TGB
TASEKO MINES LTD
-8.1%
8.1% of portfolio
IOVA
IOVANCE BIOTHERAPEUTICS INC
-42.9%
0.9% of portfolio
CPRT
COPA HOLDINGS SA
-72.2%
0.3% of portfolio

Sector Breakdown

Other100.0%

🚪 Exited Positionssold since Q3 2025

WGO
WINNEBAGO INDS INC
SOLD
$1.3M
ALK
ALASKA AIR GROUP INC
SOLD
$1.2M
ICLR
ICON PLC
SOLD
$1.2M
PFE
PFIZER INC
SOLD
$1.1M
IQV
IQVIA HLDGS INC
SOLD
$1.1M
+5 more exited positions

Changes from Q3 2025

NEW7 new positions
↑15 increased
↓17 decreased

Historical Filings

Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023

📌 Top Holdings

RI28.1%
RIGEL PHARMACEUTICALS INC
$9.6M
TGB8.1%
TASEKO MINES LTD
$9.6M
ALCO6.1%
ALICO INC
$7.3M
AM64.4%
AMICUS THERAPEUTICS INC
$5.3M
PLPC4.4%
PREFORMED LINE PRODS CO
$5.2M

⚖️ Compare Fund

Compare this fund's holdings with other hedge funds.

🎯 Fund Movement Signals

See AI-analyzed fund movement signals and accumulation patterns.

👤 Insider Trading

See what corporate insiders are buying and selling.